103 related articles for article (PubMed ID: 31223006)
41. Wobble-enhanced ARMS method for detection of KRAS and BRAF mutations.
Hamfjord J; Stangeland AM; Skrede ML; Tveit KM; Ikdahl T; Kure EH
Diagn Mol Pathol; 2011 Sep; 20(3):158-65. PubMed ID: 21817902
[TBL] [Abstract][Full Text] [Related]
42. Multiplex detection of KRAS mutations by a matrix-assisted laser desorption/ionization-time of flight mass spectrometry assay.
Choi HS; Min KT; Cha YS; Hong SP
Clin Biochem; 2014 Aug; 47(12):1091-7. PubMed ID: 24726492
[TBL] [Abstract][Full Text] [Related]
43. Wild‑type blocking pcr coupled with internal competitive amplified fragment improved the detection of rare mutation of KRAS.
Peng J; Wei K; Zhao X; Yang K; Wang H; Zhang Y; Guo M; He J; Wu H; Li Y; Zhao N; Huang Q; Fu W
Mol Med Rep; 2017 Sep; 16(3):2726-2732. PubMed ID: 28677778
[TBL] [Abstract][Full Text] [Related]
44. The frequency of KRAS mutation detection in human colon carcinoma is influenced by the sensitivity of assay methodology: a comparison between direct sequencing and real-time PCR.
Kobunai T; Watanabe T; Yamamoto Y; Eshima K
Biochem Biophys Res Commun; 2010 Apr; 395(1):158-62. PubMed ID: 20361930
[TBL] [Abstract][Full Text] [Related]
45. Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild-type tumors.
Berry W; Algar E; Kumar B; Desmond C; Swan M; Jenkins BJ; Croagh D
Int J Cancer; 2017 May; 140(10):2331-2343. PubMed ID: 28198009
[TBL] [Abstract][Full Text] [Related]
46. Enhanced asymmetric blocked qPCR method for affordable detection of point mutations in KRAS oncogene.
Lázaro A; Tortajada-Genaro LA; Maquieira Á
Anal Bioanal Chem; 2021 May; 413(11):2961-2969. PubMed ID: 33619642
[TBL] [Abstract][Full Text] [Related]
47. Surface Enhanced Raman Spectroscopy (SERS) for the Multiplex Detection of Braf, Kras, and Pik3ca Mutations in Plasma of Colorectal Cancer Patients.
Li X; Yang T; Li CS; Song Y; Lou H; Guan D; Jin L
Theranostics; 2018; 8(6):1678-1689. PubMed ID: 29556349
[TBL] [Abstract][Full Text] [Related]
48. Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer.
Brychta N; Krahn T; von Ahsen O
Clin Chem; 2016 Nov; 62(11):1482-1491. PubMed ID: 27591291
[TBL] [Abstract][Full Text] [Related]
49. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
Sakai K; Tsurutani J; Yamanaka T; Yoneshige A; Ito A; Togashi Y; De Velasco MA; Terashima M; Fujita Y; Tomida S; Tamura T; Nakagawa K; Nishio K
PLoS One; 2015; 10(5):e0121891. PubMed ID: 25954997
[TBL] [Abstract][Full Text] [Related]
50. Rapid screening assay for KRAS mutations by the modified smart amplification process.
Tatsumi K; Mitani Y; Watanabe J; Takakura H; Hoshi K; Kawai Y; Kikuchi T; Kogo Y; Oguchi-Katayama A; Tomaru Y; Kanamori H; Baba M; Ishidao T; Usui K; Itoh M; Cizdziel PE; Lezhava A; Ueda M; Ichikawa Y; Endo I; Togo S; Shimada H; Hayashizaki Y
J Mol Diagn; 2008 Nov; 10(6):520-6. PubMed ID: 18832461
[TBL] [Abstract][Full Text] [Related]
51. Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue.
Ako S; Nouso K; Kinugasa H; Dohi C; Matushita H; Mizukawa S; Muro S; Akimoto Y; Uchida D; Tomoda T; Matsumoto K; Horiguchi S; Tsutsumi K; Kato H; Okada H
Pancreatology; 2017; 17(2):285-290. PubMed ID: 28139399
[TBL] [Abstract][Full Text] [Related]
52. Eprobe-mediated screening system for somatic mutations in the KRAS locus.
Atsumi J; Hanami T; Enokida Y; Ogawa H; Delobel D; Mitani Y; Kimura Y; Soma T; Tagami M; Takase Y; Ichihara T; Takeyoshi I; Usui K; Hayashizaki Y; Shimizu K
Oncol Rep; 2015 Jun; 33(6):2719-27. PubMed ID: 25823645
[TBL] [Abstract][Full Text] [Related]
53. Quantitative and sensitive detection of rare mutations using droplet-based microfluidics.
Pekin D; Skhiri Y; Baret JC; Le Corre D; Mazutis L; Salem CB; Millot F; El Harrak A; Hutchison JB; Larson JW; Link DR; Laurent-Puig P; Griffiths AD; Taly V
Lab Chip; 2011 Jul; 11(13):2156-66. PubMed ID: 21594292
[TBL] [Abstract][Full Text] [Related]
54. Detection of
Olmedillas-López S; Lévano-Linares DC; Alexandre CLA; Vega-Clemente L; Sánchez EL; Villagrasa A; Ruíz-Tovar J; García-Arranz M; García-Olmo D
World J Gastroenterol; 2017 Oct; 23(39):7087-7097. PubMed ID: 29093617
[TBL] [Abstract][Full Text] [Related]
55. High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues.
Ney JT; Froehner S; Roesler A; Buettner R; Merkelbach-Bruse S
Arch Pathol Lab Med; 2012 Sep; 136(9):983-92. PubMed ID: 22938585
[TBL] [Abstract][Full Text] [Related]
56. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
Nam SK; Yun S; Koh J; Kwak Y; Seo AN; Park KU; Kim DW; Kang SB; Kim WH; Lee HS
PLoS One; 2016; 11(3):e0151865. PubMed ID: 26991109
[TBL] [Abstract][Full Text] [Related]
57. KRAS testing in clinical laboratory: optimizing targeted therapy.
Miravalle L; Lefferts JA; Al-Haddad M; Tsongalis GJ; Cheng L
Cancer Genomics Proteomics; 2012; 9(5):337-41. PubMed ID: 22990113
[TBL] [Abstract][Full Text] [Related]
58. Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer.
Nicoś M; Krawczyk P; Jarosz B; Sawicki M; Szumiłło J; Trojanowski T; Milanowski J
Clin Exp Med; 2016 May; 16(2):169-76. PubMed ID: 25902737
[TBL] [Abstract][Full Text] [Related]
59. Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study.
Yoshino T; Muro K; Yamaguchi K; Nishina T; Denda T; Kudo T; Okamoto W; Taniguchi H; Akagi K; Kajiwara T; Hironaka S; Satoh T
EBioMedicine; 2015 Apr; 2(4):317-23. PubMed ID: 26137573
[TBL] [Abstract][Full Text] [Related]
60. Sequence-specific preconcentration of a mutation prone KRAS fragment from plasma using ion-tagged oligonucleotides coupled to qPCR compatible magnetic ionic liquid solvents.
Emaus MN; Varona M; Anderson JL
Anal Chim Acta; 2019 Aug; 1068():1-10. PubMed ID: 31072469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
